Vol 5 (2020): Continuous Publishing
Case report
Published online: 2020-07-09

open access

Page views 873
Article views/downloads 780
Get Citation

Connect on Social Media

Connect on Social Media

Primary apocrine adenocarcinoma of the orbit with lacrimal sac invasion

Mona Mohammad1, Rashed M. Nazzal2, Maysa AlHussaini3, Niveen Abdullah3, Alaa Saleh4, Sana' Muhsen5, Robert Rejdak6, Yacoub A. Yacoub
Ophthalmol J 2020;5:38-41.

Abstract

Background: Orbital adenocarcinoma usually is metastatic and rarely can be primary disease of the orbit with no clear standard of care. Herein, we report a case of primary apocrine adenocarcinoma in the orbit with invasion into lacrimal sac in a young patient.

Case report: A 38-year-old male presented with enlarging lump in the left eye. Ocular imaging studies showed an orbital mass with invasion into the lacrimal sac and surrounding muscles. The lesion was found to be adenocarcinoma with apocrine differentiation in both pathology and immunohistochemistry. Full body imaging studies showed no extra ocular spread and no other tumors to suggest orbital metastasis. The patient was treated with orbital exenteration and was given adjuvant local radiotherapy and systemic chemotherapy because of positive margins and high risk pathological features. On serial exams over 5 years follow up, the patient was free of local recurrence or distant metastasis.

Conclusion: Orbital adenocarcinoma can present as a primary orbital tumor in young adults originating from apocrine glands, and aggressive surgical resection can be lifesaving management.

Article available in PDF format

View PDF Download PDF file

References

  1. Weedon D. Skin Pathology. Churchill Livingstone, Sydney 2002: 877888.
  2. Gesase AP, Satoh Y. Apocrine secretory mechanism: recent findings and unresolved problems. Histol Histopathol. 2003; 18(2): 597–608.
  3. Stoeckelhuber M, Stoeckelhuber BM, Welsch U. Human glands of Moll: histochemical and ultrastructural characterization of the glands of Moll in the human eyelid. J Invest Dermatol. 2003; 121(1): 28–36.
  4. Paties C, Taccagni GL, Papotti M, et al. Apocrine carcinoma of the skin. A clinicopathologic, immunocytochemical, and ultrastructural study. Cancer. 1993; 71(2): 375–381.
  5. Barker-Griffith AE, Streeten BW, Charles NC. Moll gland neoplasms of the eyelid: a clinical and pathological spectrum in 5 cases. Arch Ophthalmol. 2006; 124(11): 1645–1649.
  6. Warkel RL, Helwig EB. Apocrine gland adenoma and adenocarcinoma of the axilla. Arch Dermatol. 1978; 114(2): 198–203.
  7. Kipkie GF, Haust MD. Carcinoma of apocrine glands; report of case. AMA Arch Derm. 1958; 78(4): 440–445.
  8. Mazoujian G, Pinkus GS, Davis S, et al. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol. 1983; 110(2): 105–112.
  9. Hood CI, Font RL, Zimmerman LE. Metastatic mammary carcinoma in the eyelid with histiocytoid appearance. Cancer. 1973; 31(4): 793–800.
  10. Figueira EC, Danks J, Watanabe A, et al. Apocrine adenocarcinoma of the eyelid: case series and review. Ophthalmic Plast Reconstr Surg. 2013; 29(6): 417–423.
  11. Hoang A. Apocrine Adenocarcinoma of Lacrimal Sac Presenting as Chronic Dacryocystitis. J Ophthal Clin Res. 2017; 4(1): 1–2.
  12. Shintaku M, Tsuta K, Yoshida H, et al. Apocrine adenocarcinoma of the eyelid with aggressive biological behavior: report of a case. Pathol Int. 2002; 52(2): 169–173.
  13. Kominami R, Yasutaka S, Taniguchi Y, et al. Anatomy and histology of the lacrimal fluid drainage system. Okajimas Folia Anat Jpn. 2000; 77(5): 155–160.